Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Studies of the enzymatic deamination of cytosine arabinoside. II. Properties of the deaminase of human liver.

× No keyword cloud information.

8 in total

1. Imexon enhances gemcitabine cytotoxicity by inhibition of ribonucleotide reductase.

Authors: Nicholas O Roman; Betty K Samulitis; Lee Wisner; Terry H Landowski; Robert T Dorr
Journal: Cancer Chemother Pharmacol Date: 2010-03-26 Impact factor: 3.333

2. Purification and properties of cytidine deaminase from normal and leukemic granulocytes.

Authors: B A Chabner; D G Johns; C N Coleman; J C Drake; W H Evans
Journal: J Clin Invest Date: 1974-03 Impact factor: 14.808

3. Animal scale-up.

Authors: R L Dedrick
Journal: J Pharmacokinet Biopharm Date: 1973-10

4. The relationship of Ara-C metabolism in vitro to therapeutic response in acute myeloid leukaemia.

Authors: A L Harris; D G Grahame-Smith
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333

Review 5. Dose-dependent pharmacokinetics and cancer chemotherapy.

Authors: G Powis; M M Ames; J S Kovach
Journal: Cancer Chemother Pharmacol Date: 1981 Impact factor: 3.333

6. Imexon-based combination chemotherapy in A375 human melanoma and RPMI 8226 human myeloma cell lines.

Authors: Julie Scott; Robert T Dorr; Betty Samulitis; Terry H Landowski
Journal: Cancer Chemother Pharmacol Date: 2007-02-28 Impact factor: 3.333

7. Pharmacokinetics of cytosine arabinoside in patients with acute myeloid leukaemia.

Authors: A L Harris; C Potter; C Bunch; J Boutagy; D J Harvey; D G Grahame-Smith
Journal: Br J Clin Pharmacol Date: 1979-09 Impact factor: 4.335

8. Interaction of 6-thioguanine and cytosine arabinoside in cultured cells from patients with acute myeloid leukaemia.

Authors: A B Robins
Journal: Br J Cancer Date: 1978-11 Impact factor: 7.640

8 in total